Leica Biosystems Expands FDA-Cleared Digital Pathology
Vista, California, August,11, 2026 Leica Biosystems, a Danaher company and global provider of anatomic and digital pathology solutions, has...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Vista, California, August,11, 2026 Leica Biosystems, a Danaher company and global provider of anatomic and digital pathology solutions, has...
St. Paul, Minnesota, August,11, 2026 Zepto Life Technology has been awarded a contract valued at up to $8.9 million...
